Real-world effectiveness of drugs newly approved in Japan on survival in patients with advanced gastric cancer.

被引：0
|
作者：
Kadono, Toru
Iwasa, Satoru
Hirano, Hidekazu
Shoji, Hirokazu
Okita, Natsuko Okita
Takashima, Atsuo
Kato, Ken
机构：
[1] Natl Canc Ctr, Dept Gastrointestinal Med Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Gastrointestinal Med Oncol Div, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
322
引用
收藏
页码：322 / 322
页数：1
相关论文
共 50 条
  • [21] Real-world progression-free survival among patients with newly diagnosed advanced ovarian cancer: Does maintenance therapy work?
    Liu, Jinan
    Chan, John
    Sah, Janvi
    Maiese, Eric M.
    Bee, Oscar
    Hurteau, Jean
    Thaker, Premal H.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [22] Oncologic orphan drugs approved in the EU – do clinical trial data correspond with real-world effectiveness?
    Yvonne Schuller
    Marieke Biegstraaten
    Carla E. M. Hollak
    Heinz-Josef Klümpen
    Christine C. Gispen-de Wied
    Violeta Stoyanova-Beninska
    Orphanet Journal of Rare Diseases, 13
  • [23] Oncologic orphan drugs approved in the EU - do clinical trial data correspond with real-world effectiveness?
    Schuller, Yvonne
    Biegstraaten, Marieke
    Hollak, Carla E. M.
    Klumpen, Heinz-Josef
    Gispen-de Wied, Christine C.
    Stoyanova-Beninska, Violeta
    ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [24] Locally advanced gastric cancer under FLOT - real-world data on efficacy of patients with dMMR
    Goncalves, L.
    Pinho, M.
    Bras, R.
    Lobo, V.
    Pinho, I.
    Barroso, T.
    Patel, V.
    Lopes, C.
    Mansinho, A.
    Torres, S.
    Luis, R.
    Alvim, C.
    Costa, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S23 - S23
  • [25] Real-world delivery rate to third-line chemotherapy in patients with advanced gastric cancer
    Ueno, Masayuki
    Doi, Akira
    Mouri, Hirokazu
    Yamamoto, Hiroshi
    Mizuno, Motowo
    ANNALS OF ONCOLOGY, 2018, 29
  • [26] The real-world data in patients with advanced gastric cancer treated with ramucirumab combination chemotherapy.
    Kimura, Akie
    Sakai, Daisuke
    Kudo, Toshihiro
    Nishida, Naohiro
    Katou, Aya
    Inagaki, Chiaki
    Otsuru, Toru
    Tanaka, Koji
    Miyazaki, Yasuhiro
    Makino, Tomoki
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Yamasaki, Makoto
    Doki, Yuichiro
    Mori, Masaki
    Satoh, Taroh
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [27] Real-world treatment patterns among patients with advanced gastric cancer in South Korea.
    Carter, Gebra Cuyun
    Kaltenboeck, Anna
    Ivanova, Jasmina
    Liepa, Astra M.
    Roman, Alexandra San
    Koh, Maria
    Lee, Hyun Jung
    Rajan, Narayan
    Ballal, Shaila
    Birnbaum, Howard
    Bang, Yung-Jue
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [28] ESTIMATING THE IMPACT OF CHANNELING BIAS ON REAL-WORLD SURVIVAL IN ADVANCED CANCER
    Wiecek, W.
    Amzal, B.
    Casciano, R.
    Karcher, H.
    VALUE IN HEALTH, 2017, 20 (05) : A325 - A325
  • [29] Real-world effectiveness of ribociclib in metastatic breast cancer patients: Does dose affect survival?
    Fernandez-Cuerva, Cristina
    Chinchilla-Alarcon, Teresa
    Jose Alcaraz-Sanchez, Juan
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (07) : 1619 - 1627
  • [30] Real-world productivity, healthcare resource utilization (HRU), and quality of life (QOL) in patients with advanced gastric cancer (GC) in Korea and Japan
    Muro, K.
    Calvo, E.
    Maglinte, G.
    Rider, A.
    Contente, M.
    Middleton, C.
    Clarke, B.
    Rha, S. Y.
    ANNALS OF ONCOLOGY, 2017, 28
12345